Carrier design based on zein: From the perspectives of multi-molecule encapsulation, probiotic encapsulation, and application standards
- PMID: 40697755
- PMCID: PMC12281137
- DOI: 10.1016/j.crfs.2025.101145
Carrier design based on zein: From the perspectives of multi-molecule encapsulation, probiotic encapsulation, and application standards
Abstract
Zein is an excellent carrier material for active substances. Previous reviews have mainly focused on the encapsulation of single active molecules, while this review is for the first time to comprehensively review the design of multi-molecules and probiotics carriers, and summarize its application standards. For multi-molecule encapsulation, zein nanoparticles with core-shell structure are widely used. Based on the difference in fabrication methods and physicochemical properties of active molecules, zein nanoparticles were categorized into mixed/isolated encapsulation. Besides, zein microparticles and Pickering emulsions (with two-compartment structures for different active molecules) stabilized by zein nanoparticles as multi-molecule delivery platforms are also discussed. For carrier design of probiotics, the methods include layer-by-layer self-assembly/complex coacervation based on zein nanoparticles, microcapsules, emulsion, and probiotic biofilm formation based on zein fibers. Importantly, zein has different criteria in the food/pharmaceutical industry, which is a prerequisite for practical application. Although zein-based multi-molecule carriers have been studied extensively, most of the current work focuses on characterizing properties instead of mechanism investigation of complex systems. In the future, designing carriers with superior structures to control the release rate of different molecules and targeted colonic delivery of probiotics are the main challenges for expanding zein applications. This review is expected to guide the rapid and scientific progress of zein-based carrier design for multi-molecules and probiotics.
Keywords: Carrier; Multi-molecules; Probiotics; Zein.
© 2025 The Authors.
Conflict of interest statement
No conflict of interest exists in the submission of this manuscript, and the manuscript is approved by all authors for publication. I would like to declare on behalf of my co-authors that the review has not been published previously, and is not under consideration for publication elsewhere, in whole or in part. All the authors listed have approved the manuscript that is enclosed.
Figures





Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Short-Term Memory Impairment.2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2024 Jun 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 31424720 Free Books & Documents.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Apr 19;4:CD011535. doi: 10.1002/14651858.CD011535.pub4. PMID: 31917873 Free PMC article. Updated.
References
-
- Altay Ö., Köprüalan Ö., İlter I., Koç M., Ertekin F.K., Jafari S.M. Spray drying encapsulation of essential oils; process efficiency, formulation strategies, and applications. Crit. Rev. Food Sci. Nutr. 2024;64(4):1139–1157. - PubMed
-
- Amiri S., Nezamdoost-Sani N., Mostashari P., McClements D.J., Marszałek K., Mousavi Khaneghah A. Effect of the molecular structure and mechanical properties of plant-based hydrogels in food systems to deliver probiotics: an updated review. Crit. Rev. Food Sci. Nutr. 2024;64(8):2130–2156. - PubMed
-
- Buniowska-Olejnik M., Urbański J., Mykhalevych A., Bieganowski P., Znamirowska-Piotrowska A., Kačániová M., Banach M. The influence of curcumin additives on the viability of probiotic bacteria, antibacterial activity against pathogenic microorganisms, and quality indicators of low-fat yogurt. Front. Nutr. 2023;10 - PMC - PubMed
-
- Campos L.A.d.A., Neto A.F.S., Scavuzzi A.M.L., Lopes A.C.D.S., Santos-Magalhães N.S., Cavalcanti I.M.F. Ceftazidime/tobramycin Co-Loaded chitosan-coated zein nanoparticles against antibiotic-resistant and biofilm-producing Pseudomonas aeruginosa and Klebsiella pneumoniae. Pharmaceuticals. 2024;17(3):320. - PMC - PubMed
-
- Carrasco-Sandoval J., Aranda-Bustos M., Henríquez-Aedo K., López-Rubio A., Fabra M.J. Bioaccessibility of different types of phenolic compounds co-encapsulated in alginate/chitosan-coated zein nanoparticles. Lwt. 2021;149
Publication types
LinkOut - more resources
Full Text Sources